Failure of aggressive anticoagulant therapy in catastrophic antiphospholipid syndrome
Zoli, A.; D'Agostino, M.A.; Pompa, A.; Altomonte, L.; Mirone, L.; Magarò, A.
Clinical and Experimental Rheumatology 18(1): 113
2000
ISSN/ISBN: 0392-856X PMID: 10728460 Document Number: 518016
Document emailed within 1 workday
Related Documents
Le Loët, X.; Vittecoq, O.; Jouen-Beades, F.; Tron, F. 1997: Catastrophic antiphospholipid syndrome Presse Medicale 26(3): 131-134Wisłowska, M.łg. 2015: Catastrophic antiphospholipid syndrome Wiadomosci Lekarskie 68(3): 271-273
Vivaldi, P.; Andreotti, C.; Mazzon, C.; Pedrazzoli, M. 1994: A "primitive" catastrophic antiphospholipid syndrome Haematologica 79(2): 173-176
Larson, M.; Lindaman, B. 2019: Catastrophic Antiphospholipid Syndrome Presenting with Genitourinary Manifestations South Dakota Medicine: the Journal of the South Dakota State Medical Association 72(10): 464-466
Carlesimo, B.; Monarca, C.; Rizzo, M.I.; Conte, F.; Scuderi, N. 2011: Comparison of surgical methods in catastrophic antiphospholipid syndrome (CAPS) Il Giornale di Chirurgia 32(3): 110-112
Jacobson, T.B.; Kolade, V.O.; Kapadia, A.S. 2010: Catastrophic antiphospholipid antibody syndrome in a young woman in the postpartum period Tennessee Medicine: Journal of the Tennessee Medical Association 103(10): 35-36; 39
Saïkali, N.; Dubost, J.J.; Durif, F.; Dordain, G. 2001: Catastrophic antiphospholipid syndrome revealed by a cerebrovascular accident: a case report Revue Neurologique (Paris) 157(11 Part 1): 1424-1426
Asherson, R.A.; Shoenfeld, Y. 2000: The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome--molecular mimicry? Journal of Rheumatology 27(1): 12-14
Rafai, M.A.; Fadel, H.; Gam, I.; Hakim, K.; El-Moutawakkil, B.; Kissani, N.; Slassi, I. 2006: Reccurent stroke revealing catastrophic antiphospholipid syndrome with hepatitis C viral infection Revue Neurologique (Paris) 162(11): 1131-1134
Tektonidou, M.G.; Sotsiou, F.; Moutsopoulos, H.M. 2008: Antiphospholipid syndrome (APS) nephropathy in catastrophic, primary, and systemic lupus erythematosus-related APS Journal of Rheumatology 35(10): 1983-1988
Wisløff, F.; Sletnes, K.; Godal, H.C. 1990: Antiphospholipid syndrome and lupus anticoagulant Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 110(1): 94
Malaviya, A.N. 1991: Lupus anticoagulant, anticardiolipin antibody or antiphospholipid syndrome? Journal of the Association of Physicians of India 39(3): 239-241
Nitter-Hauge, S.; Dale, J. 1986: High complication and failure rates of anticoagulant therapy are unavoidable Zeitschrift für Kardiologie 75(Suppl 2): 293-297
Kosaka, T.; Nagase, M.; Suzuki, Y.; Kobayashi, N. 1980: Anticoagulant therapy in combination with pulse therapy--about 12 nephritic patients with nephrotic syndrome-- Nihon Jinzo Gakkai Shi 22(8): 1095-1111
Pertusi, R.M. 1992: The lupus anticoagulant and antiphospholipid antibodies Journal of the American Osteopathic Association 92(8): 1021-1025
Boffa, M.C.; Piette, J.C. 1996: Questions-answers about antiphospholipid-protein antibodies and the "antiphospholipid antibody syndrome" Annales de Medecine Interne 147 Suppl. 1: 54-56
Kühne, C.; Keitel, W.; Flach, W. 1994: Clinical relevance of the antiphospholipid syndrome. Antiphospholipid antibodies in a mixed rheumatologic patient sample Fortschritte der Medizin 112(30): 423-426
Palareti, G. 1996: Anticoagulant therapy in patients with atrial fibrillation: the experience of the Centers of Surveillance. Study group of the "Italian Study on Complications of Oral Anticoagulant Therapy" (ISCOAT) Annali Italiani di Medicina Interna: Organo Ufficiale Della Societa Italiana di Medicina Interna 11(Suppl 2): 18s-20s
Duan, S.; Luo, J.; Liu, F. 1999: Assessment of anticoagulant therapy in primary nephrotic syndrome Hunan Yi Ke da Xue Xue Bao 24(3): 301-303
Varis, J.; Kuusniemi, K.; Heiro, M.; Järveläinen, H. 2011: Blue toe syndrome--a rare but possible complication of anticoagulant therapy Duodecim; Laaketieteellinen Aikakauskirja 127(11): 1154-1157